| Participating hospitals | Nonresponders | Lung cancer cases discussed by MDT | Composition of MDT# | |||||||||
| None | Some | All new cases | Pulm/ respir | Oncol+ CTx | Oncol+radio | Surgeon | Radiol | PCP | LCNS | |||
| Albania | 1 | 1 | 25 | 0 | 0 | 5 | 3 | 0 | 50 | |||
| Austria | 4 | 1 | 3 | 8 | 12 | 3 | 10 | 5 | 3 | 11 | ||
| Belarus | 1 | 1 | 4 | 4 | 3 | 3 | 2 | 2 | 8 | |||
| Belgium | 11 | 2 | 9 | 3 | 7 | 3 | 2 | 2 | 2 | 0 | ||
| Bosnia-Herzegovina | 2 | 2 | 10 | 7.5 | 0 | 0 | 0 | 1.5 | 5 | |||
| Bulgaria | 4 | 1 | 1 | 2 | 15 | 9 | 1 | 8 | 1 | 0 | 0 | |
| Croatia | 3 | 2 | 1 | 15 | 19 | 4 | 3 | 4 | 1 | 10 | ||
| Cyprus | 1 | 1 | ||||||||||
| Czech | 3 | 1 | 2 | 17.5 | 7.5 | 5 | 3.5 | 3 | 1 | 14 | ||
| Denmark | 8 | 3 | 5 | 3.5 | 4 | 2 | 4 | 2.5 | 2 | 8.5 | ||
| England | 53 | 1 | 1 | 51 | 3 | 2 | 1 | 0 | 2 | 1 | 2 | |
| Estonia | 1 | 1 | 10 | 2 | 2 | 2 | 0 | 0 | 0 | |||
| Finland | 10 | 1 | 1 | 4 | 4 | 6 | 6 | 3 | 3 | 2 | 1 | 0 |
| France | 59 | 3 | 7 | 49 | 3 | 4 | 1 | 1 | 2 | 2 | 2.5 | |
| Germany | 36 | 6 | 2 | 28 | 5 | 5 | 4 | 4 | 3 | 2 | 2.5 | |
| Greece | 2 | 2 | 6 | 2 | 1 | 2 | 1 | 1 | 0 | |||
| Hungary | 5 | 5 | 9 | 9 | 0 | 3 | 2 | 2 | 5 | |||
| Ireland | 4 | 4 | 3.75 | 2.5 | 2.5 | 2 | 2.5 | 1 | 2 | |||
| Israel | 1 | 1 | 3 | 3 | 0 | 4 | 2 | 1 | 2 | |||
| Italy | 5 | 1 | 3 | 1 | 4 | 5 | 3 | 4 | 3 | 2 | 0 | |
| Lithuania | 3 | 2 | 1 | 5 | 6 | 3 | 3 | 2 | 2 | 10 | ||
| Luxembourg | 1 | 1 | 6 | 2 | 0 | 2 | 1 | 1 | 5 | |||
| Malta | 1 | 1 | 5 | 3 | 3 | 3 | 0 | 0 | 0 | |||
| Netherlands | 13 | 1 | 5 | 7 | 4.5 | 4 | 4 | 3 | 2 | 2.5 | 2 | |
| Norway | 18 | 1 | 2 | 13 | 2 | 3 | 3 | 0 | 0 | 1 | 1 | 2 |
| Poland | 3 | 2 | 1 | 45 | 65 | 5 | 15 | 1 | 4 | 104 | ||
| Portugal | 10 | 1 | 4 | 5 | 4 | 4 | 1 | 1 | 2 | 2 | 2 | |
| FYROM | 1 | 1 | 10 | 10 | 10 | 8.5 | 10 | 5 | 20 | |||
| Republic of Serbia | 5 | 1 | 2 | 2 | 12 | 5.5 | 3.5 | 4 | 3 | 3.5 | 10 | |
| Romania | 4 | 2 | 1 | 1 | 4.5 | 4 | 1 | 2 | 1 | 6 | 0 | |
| Scotland | 11 | 2 | 9 | 3 | 1 | 1 | 0 | 2 | 2 | 1.5 | ||
| Slovakia | 3 | 2 | 1 | 10 | 4 | 0 | 0 | 1 | 1 | 2 | ||
| Slovenia | 4 | 4 | 2.5 | 5 | 4.5 | 1 | 3.5 | 1.5 | 10 | |||
| Spain | 32 | 9 | 8 | 15 | 5.5 | 4 | 2 | 2 | 2 | 2 | 1.5 | |
| Sweden | 1 | 1 | ||||||||||
| Switzerland | 7 | 2 | 5 | 4 | 8 | 3 | 1 | 2 | 2 | 0 | ||
| Turkey | 18 | 4 | 11 | 3 | 5.5 | 11 | 3 | 2.5 | 2 | 2 | 9 | |
| Wales | 1 | 1 | 3 | 1 | 1 | 0 | 3 | 2 | 2 | |||
| Total | 350 | 43 | 6 | 81 | 220 | |||||||
Data are presented as n, or median for composition of MDT. Pulm/respir: pulmonologist/respiratory physician; oncol+CTx: oncologist who gives chemotherapy; oncol+radio: oncologist who gives radiotherapy; radiol: radiologist; PCP: palliative care physician; LCNS: lung cancer nurse specialist; FYROM: Former Yugoslav Republic of Macedonia. #: median number of specialists (fulltime equivalent) who participate in MDT meetings.